PANCREATIC CANCER IN 2015: Precision medicine in pancreatic cancer — fact or fiction?

    loading  Checking for direct PDF access through Ovid

Abstract

Late diagnosis and an inability to personalize treatment are major problems preventing reductions in pancreatic cancer mortality. In 2015, the identification of a highly discriminatory exosomal biomarker, culture systems that recapitulate human disease and new methods of analysing large data sets to identify prognostic markers have improved the future outlook for patients with this cancer.

Related Topics

    loading  Loading Related Articles